Use of Antipsychotic Medications in Non-Substance-Related Delirium—the Gap Between Research Findings and Clinical Practices
- 51 Downloads
Purpose of the review
Gaps exist between the research knowledge base and clinical practices pertaining to the use of antipsychotics in delirium. We reviewed 19 major randomized studies on the use of antipsychotics in non-substance-related delirium to understand factors contributing to this gap.
Based on limited literature, antipsychotics are not effective in treating delirium in patients who are mechanically ventilated intensive care unit patients and those in palliative care, but they may be effective in preventing delirium in high-risk patients after elective surgery. The literature on the use of antipsychotics for delirium in general hospital patients is less clear.
Delirium is a complex and heterogeneous syndrome and is influenced by several individual and clinical factors, which make researching its pharmacological treatment very difficult. Furthermore, heterogeneity of the studies is a barrier to reliable meta-analyses. Until methodologically sound literature pertinent to specific patient populations and clinical scenarios accumulates, we should use both the research literature and clinical expertise to formulate practice guidelines.
KeywordsAntipsychotics Delirium Prevention Treatment Guidelines
Compliance with ethical standards
Conflict of interest
The authors declare that they have no conflict of interest.
Human and animal rights and informed consent
This article does not contain any studies with human or animal subjects performed by any of the authors.
References and Recommended Reading
Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance
- 2.• Meagher DJ, Leonard M, Donnelly S, Conroy M, Adamis D, Trzepacz PT. A longitudinal study of motor subtypes in delirium: relationship with other phenomenology, etiology, medication exposure and prognosis. J Psychosom Res. 2011;71(6):395–403. An excellent study on the motor subtypes of delirium in palliative care patients. https://doi.org/10.1016/j.jpsychores.2011.06.001.CrossRefPubMedGoogle Scholar
- 3.Ryan DJ, O'Regan NA, Caoimh RO, Clare J, O'Connor M, Leonard M, et al. Delirium in an adult acute hospital population: predictors, prevalence and detection. BMJ Open. 2013;7:3(1).Google Scholar
- 8.•• Meagher DJ, McLoughlin L, Leonard M, Hannon N, Dunne C, O'Regan N. What do we really know about the treatment of delirium with antipsychotics? Ten key issues for delirium pharmacotherapy. Am J Geriatr Psychiatry. 2013;21(12):1223–1238. The publication highlights very important questions that need to be addressed with regards to the use of antipsychotics in delirium. https://doi.org/10.1016/j.jagp.2012.09.008.CrossRefPubMedGoogle Scholar
- 9.Meagher D, Agar MR, Teodorczuk A. Debate article: Antipsychotic medications are clinically useful for the treatment of delirium. Int J Geriatr Psychiatry 2017; 30.Google Scholar
- 11.Barr J, Fraser GL, Puntillo K, Ely EW, Gelinas C, Dasta JF, et al. Clinical practice guidelines for the management of pain, agitation, and delirium in adult patients in the intensive care unit. Crit Care Med. 2013;41(1):263–306. https://doi.org/10.1097/CCM.0b013e3182783b72.CrossRefPubMedGoogle Scholar
- 15.Agar MR, Lawlor PG, Quinn S, Draper B, Caplan GA, Rowett D, et al. Efficacy of oral risperidone, haloperidol, or placebo for symptoms of delirium among patients in palliative care: a randomized clinical trial. JAMA Intern Med. 2017;177(1):34–42. https://doi.org/10.1001/jamainternmed.2016.7491.CrossRefPubMedGoogle Scholar
- 16.Devlin JW, Roberts RJ, Fong JJ, Skrobik Y, Riker RR, Hill NS, et al. Efficacy and safety of quetiapine in critically ill patients with delirium: a prospective, multicenter, randomized, double-blind, placebo-controlled pilot study. Crit Care Med. 2010;38(2):419–27. https://doi.org/10.1097/CCM.0b013e3181b9e302.CrossRefPubMedGoogle Scholar
- 17.Girard TD, Pandharipande PP, Carson SS, Schmidt GA, Wright PE, Canonico AE, et al. Feasibility, efficacy, and safety of antipsychotics for intensive care unit delirium: the MIND randomized, placebo-controlled trial. Crit Care Med. 2010;38(2):428–37. https://doi.org/10.1097/CCM.0b013e3181c58715.CrossRefPubMedPubMedCentralGoogle Scholar
- 18.Page VJ, Ely EW, Gates S, Zhao XB, Alce T, Shintani A, et al. Effect of intravenous haloperidol on the duration of delirium and coma in critically ill patients (Hope-ICU): a randomised, double-blind, placebo-controlled trial. Lancet Respir Med. 2013;1(7):515–23. https://doi.org/10.1016/S2213-2600(13)70166-8.CrossRefPubMedPubMedCentralGoogle Scholar
- 21.Kalisvaart KJ, de Jonghe JF, Bogaards MJ, Vreeswijk R, Egberts TC, Burger BJ, et al. Haloperidol prophylaxis for elderly hip-surgery patients at risk for delirium: a randomized placebo-controlled study. J Am Geriatr Soc. 2005;53(10):1658–66. https://doi.org/10.1111/j.1532-5415.2005.53503.x.CrossRefPubMedGoogle Scholar
- 22.Kaneko T. Prophylactic consecutive administration of haloperidol can reduce the occurrence of postoperative delirium in gastrointestinal surgery. Yonago Acta Med. 1999;42:179–84.Google Scholar
- 23.Larsen KA, Kelly SE, Stern TA, Bode RH Jr, Price LL, Hunter DJ, et al. Administration of olanzapine to prevent postoperative delirium in elderly joint-replacement patients: a randomized, controlled trial. Psychosomatics. 2010;51(5):409–18. https://doi.org/10.1016/S0033-3182(10)70723-4.CrossRefPubMedGoogle Scholar
- 26.Breitbart W, Marotta R, Platt MM, Weisman H, Derevenco M, Grau C, et al. A double-blind trial of haloperidol, chlorpromazine, and lorazepam in the treatment of delirium in hospitalized AIDS patients. Am J Psychiatry. 1996;153(2):231–7. https://doi.org/10.1176/ajp.153.2.231.CrossRefPubMedGoogle Scholar
- 34.•• Farewell D, Tahir TA, Bisson J. Statistical methods in randomised controlled trials for delirium. J Psychosom Res. 2012;73(3):197–204. The publication discusses important statistical aspects of randomized-controlled trials on delirium. https://doi.org/10.1016/j.jpsychores.2012.06.002.CrossRefPubMedPubMedCentralGoogle Scholar
- 37.Vochteloo AJ, Moerman S, van der Burg BL, de B M, de Vries MR, Niesten DD, et al. Delirium risk screening and haloperidol prophylaxis program in hip fracture patients is a helpful tool in identifying high-risk patients, but does not reduce the incidence of delirium. BMC Geriatr. 2011;11(1):39. https://doi.org/10.1186/1471-2318-11-39.CrossRefPubMedPubMedCentralGoogle Scholar
- 48.• Flurie RW, Gonzales JP, Tata AL, Millstein LS, Gulati M. Hospital delirium treatment: continuation of antipsychotic therapy from the intensive care unit to discharge. Am J Health Syst Pharm. 2015;72(23 Suppl 3):S133–S139. The study identifies that antipsychotics initiated for delirium are continued in many patients even after the resolution of delirium. https://doi.org/10.2146/ajhp150474.CrossRefPubMedGoogle Scholar
- 50.•• Hasnain M, Rudnick A, Bonnell W, Remington G, Lam R. Use of Placebo in Clinical Trials of Psychotropic Medication (Canadian Psychiatric Association Position Paper). Can J Psychiatry. 2017; In press. The paper discusses important clinical and ethical aspects of the use of plaebo in clinical trials of psychotropic drugs.Google Scholar